XTL Biopharmaceuticals Ltd - American Depositary Shares — Cash Flow (NASDAQ:XTLB)

Financials

Cash from operating activities 850 K1.05 M901 K707 K1.62 M — Cash from investing activities 32 K8 00036 K41 K844 K — Cash from financing activities —385 K385 K01.45 M — Free cash flow 850 K1.05 M901 K707 K1.62 M —

新闻

XTL生物制药公司收到纳斯达克摘牌通知

XTL Biopharmaceuticals faces Nasdaq delisting notice

XTL生物制药因纳斯达克摘牌通知股价下跌

XTL Biopharmaceuticals stock falls on Nasdaq delisting notice

XTL生物制药股东批准增加股本及私募配售

XTL Biopharmaceuticals shareholders approve share capital increase and private placement

XTL Biopharmaceuticals子公司Social Proxy因法院命令进入清算程序

XTL Biopharmaceuticals subsidiary Social Proxy enters liquidation following court order

XTL生物制药推进NeuroNOS收购并计划私募融资

XTL Biopharmaceuticals moves forward with NeuroNOS acquisition and plans private placement

XTL生物制药子公司向以色列法院申请破产程序

XTL Biopharmaceuticals subsidiary files for insolvency in Israeli court